Sign In
Buy GSK
$51.53
+0.0200 (+0.0388%)
At Close: Aug 04, 2026
GSK agrees HIV deal that gives lower income nations access to drug
06:33am, Thursday, 30'th Mar 2023
GSK PLC (LSE:GSK, NYSE:GSK) has entered into agreements with three firms to produce affordable generic versions of its long-lasting HIV prevention drug, cabotegravir, for use in lower-income countries
J&J backs out of RSV vaccine race with rivals Pfizer and GSK
12:28pm, Wednesday, 29'th Mar 2023
J&J lagged behind rival drugmakers Pfizer and GSK, both of which made major strides toward U.S. approval of their RSV vaccines in the last month.
J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out
11:05am, Wednesday, 29'th Mar 2023
Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out. The post J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out appear
GSK's Jemperli Effective Against First-Line Endometrial Cancer
04:45pm, Tuesday, 28'th Mar 2023
A late-stage study data shows that GSK's Jemperli reduced disease progression risk or death by 72% for treating adult patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:57am, Monday, 27'th Mar 2023
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Recent Stock Purchase March 2023
07:23am, Saturday, 25'th Mar 2023
I make a stock purchase every single month no matter what is going on in the world and despite the doom and gloom headlines. This month, I went heavier than I normally do, deploying over $3,000.
GSK Stock Skids On Judge's New Ruling As Zantac Trial Looms
11:03am, Friday, 24'th Mar 2023
A California judge will allow expert testimony linking GSK's heartburn drug Zantac to cancer. The decision took a bite out of GSK stock Friday.
GSK falls after Zantac expert opinion ruling in California litigation
08:13am, Friday, 24'th Mar 2023
GSK PLC (LSE:GSK, NYSE:GSK) shares fell 3.6% after it said it "respectfully disagrees" with a ruling by a California state court in litigation related to claims that the company's former heartburn
GSK says it disagrees with California state court ruling on Zantac
06:13am, Friday, 24'th Mar 2023
U.K. pharmaceutical giant GSK on Friday said it disagreed with a California state court ruling on Zantac, or ranitidine, and its links with cancer. “Following the 13 epidemiological studies conducte
Top 40 High-Yield Blue-Chip U.K. Stocks: Spring 2023
10:16pm, Wednesday, 22'nd Mar 2023
Much has changed since the last update in September, with banks now hogging many of the top spots. Bank shares have gone down in the last couple of weeks and their dividend yields have gone up, becaus
Better RSV Vaccine Stock: Pfizer, GSK, or Moderna?
08:45am, Friday, 17'th Mar 2023
The vaccine's revenue would help Pfizer make up for looming patent cliffs. GSK's annual financials were the healthiest of the three companies.
GSK rises as Deutsche upgrades to buy with 1,700p target
04:42am, Friday, 17'th Mar 2023
GSK PLC (LSE:GSK, NYSE:GSK)'s shares jumped 1.8% in early exchanges in London supported by an upgrade by Deutsche Bank. The German investment bank has put the FTSE 100-listed pharma giant on its ‘bu
Johnson & Johnson: Creating Shareholder Value
03:42pm, Tuesday, 14'th Mar 2023
Johnson & Johnson ( JNJ , Financial), one of the world's largest health care companies, has been making waves in the industry with its diverse pharmaceutical pipeline, a mix of opportunities and chall
GSK scores phase III success with meningococcal disease vaccine
03:43am, Tuesday, 14'th Mar 2023
GSK PLC (LSE:GSK, NYSE:GSK) has announced positive results from its phase III trial of its MenABCWY combination vaccine candidate in meningococcal, a major cause of meningitis and septicaemia. The dru
3 High Dividend Stocks With Attractive Total Return Potential
03:11pm, Friday, 10'th Mar 2023
In the current economic climate of rising interest rates, persistent inflation, simmering geopolitical risks and looming recessionary threats, it's crucial to prioritize quality, safety and high divid
